§ Player · Midfielder

Qazim Laci

Sparta Praha

In the 2024-25 Champions League, Qazim Laci has an NVP of 60.

They produce 1.01 times their position's average and cost 0.86 times as much.

Their strongest skill is Dribbler: S, percentile 97.

They have a rating in 8 matches that season and were player of the match in 0. Their best rating was 74, in Bayer 04 Leverkusen 2–0 Sparta Praha.

Seasons

SeasonCompetitionTeamMinGAProducesCostsNVP
2024-25 Champions League Sparta Praha 58210 1.01× 0.86× 60

Skills

Percentile against players in the same position in the 2024-25 Champions League, as on the app card.

StrikerB62
CreatorX18
DribblerS97
DefenderA83
ControlX33

Latest matches

  1. 74 Bayer 04 Leverkusen 2–0 Sparta Praha29 Jan · Champions League · 85'
  2. 51 Sparta Praha 0–1 Inter22 Jan · Champions League · 90'
  3. 30 Feyenoord 4–2 Sparta Praha11 Dec · Champions League · 22'
  4. 54 Sparta Praha 0–6 Atlético de Madrid26 Nov · Champions League · 79'
  5. 51 Sparta Praha 1–2 Brest6 Nov · Champions League · 62'
  6. 32 Manchester City 5–0 Sparta Praha23 Oct · Champions League · 90'
  7. 50 VfB Stuttgart 1–1 Sparta Praha1 Oct · Champions League · 70'
  8. 50 Sparta Praha 3–0 Salzburg18 Sep · Champions League · 84'

Best matches

  1. 74 Bayer 04 Leverkusen 2–0 Sparta Praha29 Jan 2025 · Champions League
  2. 54 Sparta Praha 0–6 Atlético de Madrid26 Nov 2024 · Champions League
  3. 51 Sparta Praha 1–2 Brest6 Nov 2024 · Champions League
  4. 51 Sparta Praha 0–1 Inter22 Jan 2025 · Champions League
  5. 50 Sparta Praha 3–0 Salzburg18 Sep 2024 · Champions League

How is the rating calculated?

The rating measures a single match: what the player produced against what they cost, compared with the average for their position in that league and season, and adjusted by position (a 70 for a forward is as hard to get as a 70 for a defender). A normal match is around 50, 70 is already very good and only one in a hundred goes above 80. It is not the NVP, which ranks the whole season.

See their card in La Lente All their metrics, recent form, comparisons and Same DNA.